Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06949644

Pupillometry in Delayed Sleep Wake Phase Disorder

Pupillometry in DSWPD Type 1 and Type 2

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
220 (estimated)
Sponsor
Northwestern University · Academic / Other
Sex
All
Age
16 Years
Healthy volunteers
Not accepted

Summary

The goal of this observational study is to characterize the pupil light response in patients with delayed sleep-wake phase disorder. A subset of participants will take part in a clinical trial to determine if increasing serotonin can alter the circadian response to light. The main questions it aims to answer is: Are there differences in the light response in patients with delayed sleep-wake phase disorder? Does citalopram increase melatonin suppression in patients with delayed sleep-wake phase disorder? Participants will complete activity and melatonin testing at home to determine their circadian timing. This will be followed by an eye test looking at the pupil response to different light stimuli. A subset of participants will complete two inpatient admissions where melatonin levels will be sampled and they will be exposed to a bright light. During one round of testing they will receive a placebo and in the other round of testing they will take a single dose of citalopram, a selective serotonin reuptake inhibitor.

Conditions

Interventions

TypeNameDescription
COMBINATION_PRODUCTLight and CitalopramParticipants will receive placebo or citalopram, followed by bright light exposure

Timeline

Start date
2025-09-01
Primary completion
2029-02-28
Completion
2029-07-31
First posted
2025-04-29
Last updated
2026-04-08

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT06949644. Inclusion in this directory is not an endorsement.